TRIM3, a tumor suppressor linked to regulation of p21 Waf1/Cip1

Oncogene

Volumn 33, Issue 3, 2014, Pages 308-315

  Liu, Y ^a   Raheja, R ^a   Yeh, N ^a   Ciznadija, D ^a   Pedraza, A M ^b   Ozawa, T ^c   Hukkelhoven, E ^a   Erdjument Bromage, H ^a   Tempst, P ^a   Gauthier, N P ^a   Brennan, C ^b   Holland, E C ^c   Koff, A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Human Oncology and Pathogenesis Program   (United States)

^c Cancer Biology   (United States)

Author keywords

glioma; p21; PDGF; stem progenitor; TRIM3

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21;

ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENICITY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL RENEWAL; CHROMOSOME 11P; CONTROLLED STUDY; DROSOPHILA; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH DISORDER; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRIM3 GENE; TUMOR GROWTH; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CARRIER PROTEINS; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOBLOTTING; LOSS OF HETEROZYGOSITY; MICE; MICE, KNOCKOUT; MUTATION; PROTEIN BINDING; RNA INTERFERENCE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84892633406     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.596     Document Type: Article

References (55)

1. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 2010; 10: 319-331.
2. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A et al. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PloS one 2009; 4: e7752.
3. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-1812.
4. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell 2010; 17: 98-110.
5. Vitucci M, Hayes DN, Miller CR. Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy. Br J Cancer 2011; 104: 545-553.
6. Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, Holland EC et al. Self-renewal does not predict tumor growth potential in mouse models of highgrade glioma. Cancer cell 2012; 21: 11-24.
7. Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 2012; 149: 36-47.
8. Boulay JL, Stiefel U, Taylor E, Dolder B, Merlo A, Hirth F. Loss of heterozygosity of TRIM3 in malignant gliomas. BMC cancer 2009; 9: 71.
9. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005; 3: 799-808.
10. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011; 11: 792-804.
11. Wulczyn FG, Cuevas E, Franzoni E, Rybak A. MiRNA need a TRIM regulation of miRNA activity by Trim-NHL proteins. Adv Exp Med Biol 2010; 700: 85-105.
12. Reichert H. Drosophila neural stem cells: cell cycle control of self-renewal, differentiation, and termination in brain development. Results Probl Cell Differ 2011; 53: 529-546.
13. Arama E, Dickman D, Kimchie Z, Shearn A, Lev Z. Mutations in the beta-propeller domain of the Drosophila brain tumor (brat) protein induce neoplasm in the larval brain. Oncogene 2000; 19: 3706-3716.
14. Betschinger J, Mechtler K, Knoblich JA. Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell 2006; 124: 1241-1253.
15. Bowman SK, Rolland V, Betschinger J, Kinsey KA, Emery G, Knoblich JA. The tumor suppressors Brat and Numb regulate transit-amplifying neuroblast lineages in Drosophila. Dev Cell 2008; 14: 535-546.
16. Lee CY, Wilkinson BD, Siegrist SE, Wharton RP, Doe CQ. Brat is a Miranda cargo protein that promotes neuronal differentiation and inhibits neuroblast selfrenewal. Dev Cell 2006; 10: 441-449.
17. Januschke J, Gonzalez C. Drosophila asymmetric division, polarity and cancer. Oncogene 2008; 27: 6994-7002.
18. Bello B, Reichert H, Hirth F. The brain tumor gene negatively regulates neural progenitor cell proliferation in the larval central brain of Drosophila. Development 2006; 133: 2639-2648.
19. Choksi SP, Southall TD, Bossing T, Edoff K, de Wit E, Fischer BE et al. Prospero acts as a binary switch between self-renewal and differentiation in Drosophila neural stem cells. Dev Cell 2006; 11: 775-789.
20. Herranz H, Hong X, Perez L, Ferreira A, Olivieri D, Cohen SM et al. The miRNA machinery targets Mei-P26 and regulates Myc protein levels in the Drosophila wing. EMBO J 2010; 29: 1688-1698.
21. Schwamborn JC, Berezikov E, Knoblich JA. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 2009; 136: 913-925.
22. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell stem cell 2009; 4: 226-235.
23. Charles N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell stem cell 2010; 6: 141-152.
24. Charles NA, Holland EC. TRRAP and the maintenance of stemness in gliomas. Cell stem cell 2010; 6: 6-7.
25. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15: 1913-1925.
26. Katz AM, Amankulor NM, Pitter K, Helmy K, Squatrito M, Holland EC. Astrocytespecific expression patterns associated with the PDGF-induced glioma microenvironment. PloS one 2012; 7: e32453.
27. Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 2004; 64: 4783-4789.
28. Ciznadija D, Liu Y, Pyonteck SM, Holland EC, Koff A. Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma. Cancer Res 2011; 71: 6174-6183.
29. Hukkelhoven E, Liu Y, Yeh N, Ciznadija D, Blain SW, Koff A. Tyrosine phosphorylation of p21 facilitates the development of proneural glioma. J Biol Chem 2012; 287: 38523-38530.
30. Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R et al. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). EMBO J 2007; 26: 4683-4693.
31. See WL, Heinberg AR, Holland EC, Resh MD. p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo. Cell Cycle 2010; 9: 1562-1567.
32. See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A. Defective DNA doublestrand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene 2010; 29: 1720-1731.
33. Cerami E, Demir E, Schultz N, Taylor BS, Sander C. Automated network analysis identifies core pathways in glioblastoma. PloS one 2010; 5: e8918.
34. Cheung CC, Yang C, Berger T, Zaugg K, Reilly P, Elia AJ et al. Identification of BERP (brain-expressed RING finger protein) as a p53 target gene that modulates seizure susceptibility through interacting with GABA(A) receptors. Proc Natl Acad Sci USA 2010; 107: 11883-11888.
35. Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 1997; 17: 3850-3857.
36. Yan Q, Sun W, Kujala P, Lotfi Y, Vida TA, Bean AJ. CART: an Hrs/actinin-4/BERP/myosin V protein complex required for efficient receptor recycling. Mol Biol Cell 2005; 16: 2470-2482.
37. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9: 400-414.
38. Broxmeyer HE. Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function. Ann N Y Acad Sci 2012; 1266: 151-160.
39. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M et al. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 2004; 101: 17204-17209.
40. Lee J, Kim SS. The function of p27 KIP1 during tumor development. Exp Mol Med 2009; 41: 765-771.
41. Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR et al. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Mol Cell Biol 2002; 22: 2204-2219.
42. Viglietto G, Motti ML, Fusco A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 2002; 1: 394-400.
43. Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M, Kosma VM. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. Prostate 1999; 39: 8-15.
44. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 2001; 81: 341-347.
45. Baretton GB, Klenk U, Diebold J, Schmeller N, Lohrs U. Proliferation-and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. Br J Cancer 1999; 80: 546-555.
46. Ceccarelli C, Santini D, Chieco P, Lanciotti C, Taffurelli M, Paladini G et al. Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators. Int J Cancer 2001; 95: 128-134.
47. Cheung TH, Lo KW, Yu MM, Yim SF, Poon CS, Chung TK et al. Aberrant expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma. Cancer Lett 2001; 172: 93-98.
48. Ferrandina G, Stoler A, Fagotti A, Fanfani F, Sacco R, De Pasqua A et al. p21WAF1/CIP1 protein expression in primary ovarian cancer. Int J Oncol 2000; 17: 1231-1235.
49. Sarbia M, Gabbert HE. Modern pathology: prognostic parameters in squamous cell carcinoma of the esophagus. Recent Results Cancer Res 2000; 155: 15-27.
50. Winters ZE, Leek RD, Bradburn MJ, Norbury CJ, Harris AL. Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res 2003; 5: R242-R249.
51. James MK, Ray A, Leznova D, Blain SW. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol Cell Biol 2008; 28: 498-510.
52. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140-2151.
53. Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D et al. Retinoblastoma has properties of a cone precursor tumor and depends upon conespecific MDM2 signaling. Cell 2009; 137: 1018-1031.
54. Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C et al. Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130. Mol Cell Biol 2007; 27: 5161-5171.
55. Taylor BS, Barretina J, Socci ND, Decarolis P, Ladanyi M, Meyerson M et al. Functional copy-number alterations in cancer. PloS one 2008; 3: e3179.